State of Wisconsin Investment Board’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-78,900
Closed -$382K 1834
2020
Q1
$382K Buy
78,900
+18,800
+31% +$122K ﹤0.01% 1417
2019
Q4
$639K Hold
60,100
﹤0.01% 1362
2019
Q3
$626K Buy
60,100
+4,500
+8% +$58.9K ﹤0.01% 1259
2019
Q2
$852K Buy
55,600
+17,700
+47% +$256K ﹤0.01% 1180
2019
Q1
$487K Buy
37,900
+8,600
+29% +$97.2K ﹤0.01% 1354
2018
Q4
$278K Buy
29,300
+400
+1% +$5.19K ﹤0.01% 1419
2018
Q3
$480K Buy
28,900
+12,900
+81% +$207K ﹤0.01% 1408
2018
Q2
$257K Hold
16,000
﹤0.01% 1409
2018
Q1
$245K Hold
16,000
﹤0.01% 1389
2017
Q4
$250K Hold
16,000
﹤0.01% 1371
2017
Q3
$178K Hold
16,000
﹤0.01% 1404
2017
Q2
$147K Buy
+16,000
New +$133K ﹤0.01% 1422

State of Wisconsin Investment Board's STML Position: Q2 2020 in Review

State of Wisconsin Investment Board sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 78,900 shares — an estimated $382K sold.

State of Wisconsin Investment Board first reported a position in STML in Q2 2017 and held it in 12 quarters. The position peaked at $852K in Q2 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • State of Wisconsin Investment Board reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 78,900 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $382K.
  • State of Wisconsin Investment Board first reported a position in Stemline Therapeutics, Inc. in Q2 2017 and held it in 12 quarters.
  • State of Wisconsin Investment Board's Stemline Therapeutics, Inc. position peaked at $852K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2020, filed 12 Aug 2020.